Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Ye 2013 Anal Biochem"

From Bioblast
Β 
(4 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{Publication
{{Publication
|title=Ye F, Hoppel CL (2013) Measuring oxidative phosphorylation in human skin fibroblasts. Anal Biochem 437:52-8
|title=Ye F, Hoppel CL (2013) Measuring oxidative phosphorylation in human skin fibroblasts. https://doi.org/10.1016/j.ab.2013.02.010
|info=[http://www.ncbi.nlm.nih.gov/pubmed/23462540 PMID: 23462540]
|info=Anal Biochem 437:52-8. [http://www.ncbi.nlm.nih.gov/pubmed/23462540 PMID: 23462540]
|authors=Ye F, Hoppel CL
|authors=Ye F, Hoppel CL
|year=2013
|year=2013
|journal=Anal Biochem
|journal=Anal Biochem
|abstract=An approach has been developed to quantitate oxidative phosphorylation in harvested human skin fibroblasts that have been permeabilized with digitonin. In protocol 1, state 3 rates are measured with Complex I and II substrates, followed by uncoupled maximal oxidative capacity measured in the presence of these combined substrates, as well as through Complex IV. In protocol 2, state 3 rates are measured using palmitoylcarnitine to monitor fatty acid oxidation, and duroquinol to assess the flux through Complex III; uncoupled duroquinol oxidation measures maximal oxidative capacity through Complex III. The activity of citrate synthase is determined in every experiment as a marker of the amount of mitochondria per chamber. Data are expressed on the basis of cell count (per million fibroblasts), of protein, or of citrate synthase activity. Cell growth conditions are optimized and it is necessary to keep cultured cells from reaching confluency. Cultures in passages 3 to 10 show reproducible oxidative phosphorylation data. Based on the data from the 15 normal human skin fibroblast lines, we are evaluating the use of this approach to diagnose systemic mitochondrial disease and avoid issues associated with open skeletal muscle biopsy.
|abstract=An approach has been developed to quantitate oxidative phosphorylation in harvested human skin fibroblasts that have been permeabilized with digitonin. In protocol 1, state 3 rates are measured with Complex I and II substrates, followed by uncoupled maximal oxidative capacity measured in the presence of these combined substrates, as well as through Complex IV. In protocol 2, state 3 rates are measured using palmitoylcarnitine to monitor fatty acid oxidation, and duroquinol to assess the flux through Complex III; uncoupled duroquinol oxidation measures maximal oxidative capacity through Complex III. The activity of citrate synthase is determined in every experiment as a marker of the amount of mitochondria per chamber. Data are expressed on the basis of cell count (per million fibroblasts), of protein, or of citrate synthase activity. Cell growth conditions are optimized and it is necessary to keep cultured cells from reaching confluency. Cultures in passages 3 to 10 show reproducible oxidative phosphorylation data. Based on the data from the 15 normal human skin fibroblast lines, we are evaluating the use of this approach to diagnose systemic mitochondrial disease and avoid issues associated with open skeletal muscle biopsy.
|keywords=Diagnosis, Systemic mitochondrial disease
|keywords=Diagnosis; Systemic mitochondrial disease; Duroquinol oxidation; State 3 oxidation; Palmitoylcarnitine oxidation
|mipnetlab=US OH Cleveland Hoppel CL
|mipnetlab=US OH Cleveland Hoppel CL
}}
}}
{{Labeling
{{Labeling
|organism=Human
|organism=Human
|tissues=Skeletal muscle
|tissues=Skeletal muscle, Fibroblast
|model cell lines=Fibroblast
|preparations=Permeabilized cells
|preparations=Permeabilized cells
|enzymes=Complex I, Complex II;succinate dehydrogenase, Complex III, Complex IV;cytochrome c oxidase
|enzymes=Complex I, Complex II;succinate dehydrogenase, Complex III, Complex IV;cytochrome c oxidase
|topics=Fatty acid
|topics=Fatty acid
|couplingstates=OXPHOS
|couplingstates=OXPHOS
|substratestates=CI, CII, CIII, CIV
|pathways=N, S, DQ, CIV
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|additional=PLoSONE2022ace-sce
}}
}}

Latest revision as of 14:50, 4 June 2022

Publications in the MiPMap
Ye F, Hoppel CL (2013) Measuring oxidative phosphorylation in human skin fibroblasts. https://doi.org/10.1016/j.ab.2013.02.010

Β» Anal Biochem 437:52-8. PMID: 23462540

Ye F, Hoppel CL (2013) Anal Biochem

Abstract: An approach has been developed to quantitate oxidative phosphorylation in harvested human skin fibroblasts that have been permeabilized with digitonin. In protocol 1, state 3 rates are measured with Complex I and II substrates, followed by uncoupled maximal oxidative capacity measured in the presence of these combined substrates, as well as through Complex IV. In protocol 2, state 3 rates are measured using palmitoylcarnitine to monitor fatty acid oxidation, and duroquinol to assess the flux through Complex III; uncoupled duroquinol oxidation measures maximal oxidative capacity through Complex III. The activity of citrate synthase is determined in every experiment as a marker of the amount of mitochondria per chamber. Data are expressed on the basis of cell count (per million fibroblasts), of protein, or of citrate synthase activity. Cell growth conditions are optimized and it is necessary to keep cultured cells from reaching confluency. Cultures in passages 3 to 10 show reproducible oxidative phosphorylation data. Based on the data from the 15 normal human skin fibroblast lines, we are evaluating the use of this approach to diagnose systemic mitochondrial disease and avoid issues associated with open skeletal muscle biopsy. β€’ Keywords: Diagnosis; Systemic mitochondrial disease; Duroquinol oxidation; State 3 oxidation; Palmitoylcarnitine oxidation

β€’ O2k-Network Lab: US OH Cleveland Hoppel CL


Labels:


Organism: Human  Tissue;cell: Skeletal muscle, Fibroblast  Preparation: Permeabilized cells  Enzyme: Complex I, Complex II;succinate dehydrogenase, Complex III, Complex IV;cytochrome c oxidase  Regulation: Fatty acid  Coupling state: OXPHOS  Pathway: N, S, DQ, CIV  HRR: Oxygraph-2k 

PLoSONE2022ace-sce